More importantly, we analyzed the expression of HMGB3 in tumors from 360 patients with HCC, in the TCGA database, and found that HMGB3 expression is negatively associated with overall survival time for patients with HCC. The gene discussed is HMGB3; the disease is hepatocellular carcinoma.